Abstract
Retraction of ‘TRIM22 functions as an oncogene in gliomas through regulating the Wnt/β-catenin signaling pathway’ by Shi-lei Tang et al., RSC Adv., 2018, 8, 30894–30901, DOI: 10.1039/C8RA05684F.
Highlights
The images in the article were screened by an image integrity expert
The paper was analysed by experts who fact-checked the identities of the described nucleotide sequence reagents,1 and found errors with the following nucleotide sequence reagents reported in the article
The TRIM22 reverse primer is nontargeting and, the results shown in Fig. 2 are not reliable
Summary
Cite this: RSC Adv., 2021, 11, 5240 Retraction: TRIM22 functions as an oncogene in gliomas through regulating the Wnt/b-catenin signaling pathway
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
